268 related articles for article (PubMed ID: 10861823)
1. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
Liu XY; Gabig TG; Bang NU
Am J Hematol; 2000 Jul; 64(3):226-8. PubMed ID: 10861823
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Beye A; Pindur G
Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
[TBL] [Abstract][Full Text] [Related]
3. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
6. Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report.
Mitsis M; Ioannou H; Eleftheriou A; Nousias V; Basioukas C; Kakosimos G; Batsis C; Vartholomatos G
Angiology; 2000 Apr; 51(4):325-9. PubMed ID: 10779003
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous superficial vein thrombosis in a young patient double heterozygous for factor V Leiden and the prothrombin G20210A mutation: a case report.
Vayá A; Llopis I; Trenor R; Mira Y; Estellés A; Aznar J
Haematologica; 2000; 85(E-letters):E11. PubMed ID: 11114826
[No Abstract] [Full Text] [Related]
9. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
[TBL] [Abstract][Full Text] [Related]
10. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
13. Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
Bhaijee F; Jordan B; Pepper DJ; Leacock R; Rock WA
Clin Lab Sci; 2012; 25(4):199-205. PubMed ID: 23330508
[TBL] [Abstract][Full Text] [Related]
14. Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
Vayá A; Todolí J; Ricart J; Estellés T; Mira Y; Villa P; Calabuig JR; Aznar J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):72-4. PubMed ID: 11190909
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
[TBL] [Abstract][Full Text] [Related]
16. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
17. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
20. [Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors].
Bai C; Pan J; Li X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):900-2. PubMed ID: 11715503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
